Fundraising Fox

Bioventures InvestorsFull Portfolio

10 tracked investments · listed companies and verified rows first

3DBiopsyMay 2022SEC filingmedium confidence

Aurora, US

Nelson Stone(Founder)E. David Crawford(Founder)Brad Buscher(Executive Officer, Director)

Board seatJames Lousararian· per SEC Form D · $500K raise · filed Jun 2022

Biofeedback DesignOct 2020SEC filingmedium confidence

HealthtechBoston, US

Sharyn Chabot(Executive Officer)Gene Zylkuski(Executive Officer, Director)

BoardJonathan Paull Gertler(Director)inMark Goldberg(Director)

Board seatJonathan Gertler· per SEC Form D · $3.2M raise · filed Nov 2020

Brainbox Solutionsbrainboxinc.cominOct 2023

BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms.

AI & Machine LearningBiotechDigital HealthMedical DevicesHouston, US

Steve Wallace(Chief Operating Officer, Global Supply Chain Management)Donna J. Edmonds(CEO)inJames V. Snider(Chief Technology Officer / Advisor)Tim Van Meter(Chief Scientific Officer)Richard Noel(Chief Product and Commercial Officer)Robert Sledd(Director)

Co-investorsAmbit Health VenturesGenoa VenturesVTC VenturesGENERAL INCEPTION

CoNextionsconextionsmed.comin

CoNextions Medical develops implantable devices for orthopaedic soft tissue repair, including systems for tendon repair and soft tissue-to-bone fixation intended for use by surgeons.

HealthtechMedical DevicesSalt Lake City, US

Erik N. Kubiak(Co-Founder | Chairman of the Medical Advisory Board | Director)Richard J Linder(Mr. Linder is President, CEO and a director of the Issuer.)Brian Woolf(Executive Officer)Dan Gruppo(President and Chief Executive Officer)Duraid Jwayyed(Chief Financial Officer)Attila Poka(Chief Medical Officer)

Co-investorsKickstart

Endotronixendotronix.comin𝕏Mar 2014

Endotronix develops the Cordella PA Sensor and Heart Failure System, an FDA-approved implantable pulmonary artery pressure sensor and remote monitoring platform for managing patients with NYHA class III heart failure.

Digital HealthHealthtechMedical DevicesWoodridge, US

Harry Rowland(Executive Officer, Director)Anthony I Nunez(Executive Officer, Director)Anthony A. Nunez(Executive Officer, Director)Anthony Nunez(Founder)in

BoardJonathan Jonas(Director)Raymond S. Barrett, Jr.(Director)

Co-investorsJumpstart VenturesLumira VenturesOSF VenturesSeroba Life SciencesSV Health Investors

Optiviooptivio.comin𝕏

Optivio is developing a biofeedback-based SaaS platform, preparing for launch with its first customers.

AI & Machine LearningDigital HealthHealthtechMental HealthSaaS

Jonathan P. Gertler(Chairman and Co-Founder)inChristine Magyar(Chief Financial & Administrative Officer)

Sono Motionsonomotion.com

SonoMotion develops ultrasound-based medical devices for treating kidney stones, working with urologists and clinical partners.

Deep TechHealthtechMedical DevicesSan Mateo, US

Oren Levy(Chief Executive Officer, Co-Founder)Paul Douglas Corl(Executive Officer)Doug Corl(Chief Technology Officer)Michael Bailey(Executive Officer, Director)Barbrina Dunmire(Director)

UID Identification Solutionsuidevices.comin𝕏

Unified Information Devices (UID) develops RFID solutions—including implantable and external microchips, readers, home cage monitoring systems, and custom software—for identifying and tracking laboratory research animals and lab items.

BiotechHardwareIoTLake Villa, US

Verax Biomedicalveraxbiomedical.comin

Verax Biomedical develops rapid bacterial contamination detection tests for blood products and tissues intended for transfusion and transplantation.

BiotechDigital HealthHealthtechMedical DevicesMarlborough, US

JOE R. SANDERS(Executive Officer, Director)YLI REMO VALLEJO(Executive Officer)R. SCOTT MCKENZIE, SR.(Executive Officer)NANCY A. HORNBAKER(Executive Officer)inPAUL RAGUSA(Executive Officer)

BoardMARC GOLDBERG(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.